Daniel Ter-Minassian

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study

James McCarthy, Thomas Rückle, Elhadj Djeriou et al. · Malaria Journal · 2016 · 127 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study

Jana Held, Christian Supan, Carmen L. Ospina Salazar et al. · The Lancet Infectious Diseases · 2015 · 90 citations

Pharmacy, Infectious Diseases, Pharmacology +12

Pharmacokinetics of Ferroquine, a Novel 4-Aminoquinoline, in Asymptomatic Carriers of Plasmodium falciparum Infections

Christian Supan, Ghyslain Mombo‐Ngoma, Matthias P. Dal-Bianco et al. · Antimicrobial Agents and Chemotherapy · 2012 · 90 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection

Ghyslain Mombo‐Ngoma, Christian Supan, Matthias P. Dal-Bianco et al. · Malaria Journal · 2011 · 73 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15